TNF receptor 2, not TNF receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia

Shock

Volumn 33, Issue 6, 2010, Pages 602-607

  Kelly, Megan L ^a   Wang, Meijing ^a   Crisostomo, Paul R ^a   Abarbanell, Aaron M ^a   Herrmann, Jeremy L ^a   Weil, Brent R ^a   Meldrum, Daniel R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow cells; Ischemia reperfusion; Myocardial function; Paracrine effects

Indexed keywords

GROWTH FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT ANIMAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL CULTURE; CONTROLLED STUDY; DNA MODIFICATION; HEART FUNCTION; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPOTHESIS; INFUSION; ISOLATED HEART; KNOCKOUT MOUSE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PARACRINE SIGNALING; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL REPERFUSION INJURY; RATS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;

EID: 77952365320     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181cc0913     Document Type: Article

References (30)

1. Crisostomo PR, Meldrum DR: Stem cell delivery to the heart: clarifying methodology and mechanism. Crit Care Med 35:2654-2656, 2007.
2. Crisostomo PR, Wang M, Markel TA, Lahm T, Abarbanell AM, Herrmann JL, Meldrum DR: Stem cell mechanisms and paracrine effects: potential in cardiac surgery. Shock 28:375-383, 2007.
3. Tang J, Xie Q, Pan G, Wang J, Wang M: Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. Eur J Cardiothorac Surg 30:353-361, 2006.
4. Wang M, Tsai BM, Crisostomo PR, Meldrum DR: Tumor necrosis factor receptor 1 signaling resistance in the female myocardium during ischemia. Circulation 114:I282-I289, 2006.
5. Tang YL, Zhao Q, Zhang YC, Cheng L, Liu M, Shi J, Yang YZ, Pan C, Ge J, Phillips MI: Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 117:3-10, 2004.
6. Wang Y, Haider HK, Ahmad N, Xu M, Ge R, Ashraf M: Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. J Mol Cell Cardiol 40:736-745, 2006.
7. Meldrum DR: Tumor necrosis factor in the heart. Am J Physiol 274:R577-R595, 1998.
8. Shames BD, Barton HH, Reznikov LL, Cairns CB, Banerjee A, Harken AH, Meng X: Ischemia alone is sufficient to induce TNF-alpha mRNA and peptide in the myocardium. Shock 17:114-119, 2002.
9. Higuchi Y, McTiernan CF, Frye CB, McGowan BS, Chan TO, Feldman AM: Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alphaYinduced cardiomyopathy. Circulation 109:1892-1897, 2004.
10. Defer N, Azroyan A, Pecker F, Pavoine C: TNFR1 and TNFR2 signaling interplay in cardiac myocytes. J Biol Chem 282:35564-35573, 2007.
11. Wang M, Crisostomo PR, Markel TA, Wang Y, Meldrum DR: Mechanisms of sex differences in TNFR2-mediated cardioprotection. Circulation 118:38-45, 2008.
12. Crisostomo PR, Wang M, Herring CM, Markel TA, Meldrum KK, Lillemoe KD, Meldrum DR: Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1). J Mol Cell Cardiol 42:142-149, 2007.
13. Markel TA, Crisostomo PR, Wang M, Herring CM, Meldrum DR: Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production. Am J Physiol Gastrointest Liver Physiol 293: G657-G662, 2007.
14. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ: Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103:1662-1668, 2004.
15. Wang M, Sankula R, Tsai BM, Meldrum KK, Turrentine M, March KL, Brown JW, Dinarello CA, Meldrum DR: P38 MAPK mediates myocardial proinflammatory cytokine production and endotoxin-induced contractile suppression. Shock 21:170-174, 2004.
16. Wang M, Tsai BM, Kher A, Baker LB, Wairiuko GM, Meldrum DR: Role of endogenous testosterone in myocardial proinflammatory and proapoptotic signaling after acute ischemia-reperfusion. Am J Physiol Heart Circ Physiol 288:H221-H226, 2005.
17. Wang M, Tsai BM, Turrentine MW, Mahomed Y, Brown JW, Meldrum DR: p38 mitogen activated protein kinase mediates both death signaling and functional depression in the heart. Ann Thorac Surg 80:2235-2241, 2005.
18. Crisostomo PR, Markel TA, Wang M, Lahm T, Lillemoe KD, Meldrum DR: In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery 142:215-221, 2007.
19. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, et al.: Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705, 2001.
20. Laflamme MA, Myerson D, Saffitz JE, Murry CE: Evidence for cardiomyo-cyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 90:634-640, 2002.
21. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107:1395-1402, 2001.
22. Uemura R, Xu M, Ahmad N, Ashraf M: Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98:1414-1421, 2006.
23. Wang M, Tsai BM, Crisostomo PR, Meldrum DR: Pretreatment with adult progenitor cells improves recovery and decreases native myocardial proin-flammatory signaling after ischemia. Shock 25:454-459, 2006.
24. Markel TA, Wang Y, Herrmann JL, Crisostomo PR, Wang M, Novotny NM, Herring CM, Tan J, Lahm T, Meldrum DR: VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol Heart Circ Physiol 295:H2308-H2314, 2008.
25. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ: Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9:1195-1201, 2003.
26. Mhyre AJ, Marcondes AM, Spaulding EY, Deeg HJ: Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD. Blood 113:649-658, 2009.
27. Wang M, Crisostomo PR, Herring C, Meldrum KK, Meldrum DR: Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 291:R880-R884, 2006.
28. Rezzoug F, Huang Y, Tanner MK, Wysoczynski M, Schanie CL, Chilton PM, Ratajczak MZ, Fugier-Vivier IJ, Ildstad ST: TNF-alpha is critical to facilitate hemopoietic stem cell engraftment and function. J Immunol 180:49-57, 2008.
29. Caplan AI: Why are MSCs therapeutic? New data: new insight. J Pathol 217:318-324, 2008.
30. Yoo KH, Jang IK, Lee MW, Kim HE, Yang MS, Eom Y, Lee JE, Kim YJ, Yang SK, Jung HL, et al.: Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol 259:150-156, 2009.